Table 3.
Number of patients prescribed preventive medication at admission and at discharge
| UK (n = 125) | US (n = 191) | |||||
|---|---|---|---|---|---|---|
| Preventive medicine type | N (%) at admission | N (%) at discharge | P‐valuea | N (%) at admission | N (%) at discharge | P‐valuea |
| Antidiabetic | 8 (6.4) | 11 (8.8) | 0.375 | 23 (12.0) | 21 (11.0) | 0.75 |
| Antihypertensives | 59 (47.2) | 44 (35.2) | 0.001 | 97 (50.8) | 97 (50.8) | 1.000 |
| Antihyperlipidaemic | 57 (45.6) | 40 (32.0) | <0.001 | 61 (31.9) | 44 (23.0) | 0.032 |
| Antiplatelet | 38 (30.4) | 30 (24.0) | 0.057 | 39 (20.4) | 33 (17.3) | 0.307 |
| Multivitamins and minerals | 30 (24.0) | 36 (28.8) | 0.286 | 106 (55.5) | 73 (38.2) | <0.001 |
| Any preventive medicine | 91 (72.8) | 79 (63.2) | 0.017 | 152 (79.6) | 132 (69.1) | 0.002 |
a
Difference between number at admission and number at discharge, using the McNemar test